Dr. Reddy's Laboratories
(NYSE) RDY
Dr. Reddy's Laboratories Financials at a Glance
Market Cap
$11.32B
Revenue (TTM)
$337.10B
Net Income (TTM)
$42.88B
EPS (TTM)
$0.59
P/E Ratio
23.14
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Price
$13.60
Volume
723,653.873
Open
$13.55
Price
$13.60
Volume
723,653.873
Open
$13.55
Previous Close
$13.60
Daily Range
$13.48 - $13.61
52-Week Range
$12.19 - $16.17
Dividend
$0.09
Beta (Volatility)
0.43 (Low)
Price
$13.60
Volume
723,653.873
Open
$13.55
Previous Close
$13.60
Daily Range
$13.48 - $13.61
52-Week Range
$12.19 - $16.17
RDY News
What Is an Emerging Market Economy?
Is Dr. Reddy's Laboratories a Buy?
RDY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dr. Reddy's Laboratories
Industry
Pharmaceuticals
Sector
Health CareEmployees
27,811
CEO
Erez Israeli, MBA
Website
www.drreddys.comHeadquarters
Hyderabad, 500034, IN
RDY Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
15%
Net Income Margin
13%
Return on Equity
12%
Return on Capital
12%
Return on Assets
7%
Earnings Yield
4.32%
Dividend Yield
0.67%
Payout Ratio
15.54%
Stock Overview
Market Cap
$11.32B
Shares Outstanding
832.56M
Volume
723.65K
Avg. Volume
2.52M
Financials (TTM)
Gross Profit
$186.52B
Operating Income
$48.87B
EBITDA
$70.55B
Operating Cash Flow
$56.65B
Capital Expenditure
$24.54B
Free Cash Flow
$32.10B
Cash & ST Invst.
$86.08B
Total Debt
$75.81B
Dr. Reddy's Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$76.33B
-10.3%
Gross Profit
$34.22B
-27.6%
Gross Margin
44.82%
N/A
Market Cap
$11.32B
N/A
Market Cap/Employee
$418.62K
N/A
Employees
27,048
N/A
Net Income
$2.24B
-86.0%
EBITDA
$6.14B
-75.7%
Quarterly Fundamentals
Net Cash
$10.27B
-7.9%
Accounts Receivable
$99.22B
-9.6%
Inventory
$75.02B
+5.5%
Long Term Debt
$11.96B
+52.1%
Short Term Debt
$63.85B
+64.1%
Return on Assets
7.40%
N/A
Return on Invested Capital
12.07%
N/A
Free Cash Flow
$10.75B
-0.0%
Operating Cash Flow
$15.44B
-29.8%